Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38085
CAS Number:
65271-80-9
Mitoxantrone
Purity:
≥ 97 % (HPLC)
Synonym(s):
1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyéthyl)amino]éthyl]amino]anthraquinone, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyéthyl)amino]éthyl]amino]anthracène-9,10-dione
Hazmat
Documents
$97.25 /200 mg
Taille
Request Bulk Quote
Informations sur le produit
Numéro CAS 
65271-80-9
Formule moléculaire
C22H28N4O6
Poids moléculaire 
0
Point de fusion 
170 - 174 °C
Informations générales
Numéro CAS 
65271-80-9
Formule moléculaire
C22H28N4O6
Poids moléculaire 
0
Point de fusion 
170 - 174 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Mitoxantrone is widely utilized in research focused on:

  • Cancer Treatment: This compound is primarily used as a chemotherapy agent for treating various types of cancer, including leukemia and breast cancer. It works by interfering with the DNA of cancer cells, preventing their growth and reproduction.
  • Multiple Sclerosis Therapy: Mitoxantrone is also employed in the treatment of multiple sclerosis (MS). It helps reduce the frequency of relapses and slows the progression of disability in patients.
  • Cardiotoxicity Research: Researchers study the cardiotoxic effects of mitoxantrone to better understand its impact on heart health, which can lead to improved patient management strategies during chemotherapy.
  • Combination Therapy Studies: It is often used in combination with other drugs to enhance therapeutic efficacy. This approach allows researchers to explore synergistic effects and optimize treatment regimens for better outcomes.
  • Pharmaceutical Development: Mitoxantrone serves as a model compound in drug formulation studies, helping scientists develop more effective delivery systems and dosage forms for cancer therapies.

Citations